These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
237 related items for PubMed ID: 27895157
1. Beneficial Effects of Myo-Inositol Oxygenase Deficiency in Cisplatin-Induced AKI. Dutta RK, Kondeti VK, Sharma I, Chandel NS, Quaggin SE, Kanwar YS. J Am Soc Nephrol; 2017 May; 28(5):1421-1436. PubMed ID: 27895157 [Abstract] [Full Text] [Related]
2. Myo-inositol oxygenase expression profile modulates pathogenic ferroptosis in the renal proximal tubule. Deng F, Sharma I, Dai Y, Yang M, Kanwar YS. J Clin Invest; 2019 Nov 01; 129(11):5033-5049. PubMed ID: 31437128 [Abstract] [Full Text] [Related]
3. Modulation of gentamicin-induced acute kidney injury by myo-inositol oxygenase via the ROS/ALOX-12/12-HETE/GPR31 signaling pathway. Sharma I, Liao Y, Zheng X, Kanwar YS. JCI Insight; 2022 Mar 22; 7(6):. PubMed ID: 35315361 [Abstract] [Full Text] [Related]
4. Myo-inositol oxygenase accentuates renal tubular injury initiated by endoplasmic reticulum stress. Tominaga T, Sharma I, Fujita Y, Doi T, Wallner AK, Kanwar YS. Am J Physiol Renal Physiol; 2019 Feb 01; 316(2):F301-F315. PubMed ID: 30539651 [Abstract] [Full Text] [Related]
5. myo-Inositol Oxygenase Overexpression Accentuates Generation of Reactive Oxygen Species and Exacerbates Cellular Injury following High Glucose Ambience: A NEW MECHANISM RELEVANT TO THE PATHOGENESIS OF DIABETIC NEPHROPATHY. Sun L, Dutta RK, Xie P, Kanwar YS. J Biol Chem; 2016 Mar 11; 291(11):5688-5707. PubMed ID: 26792859 [Abstract] [Full Text] [Related]
6. Myo-inositol oxygenase overexpression exacerbates cadmium-induced kidney injury via oxidant stress and necroptosis. Zheng X, Deng F, Sharma I, Kanwar YS. Am J Physiol Renal Physiol; 2022 Mar 01; 322(3):F344-F359. PubMed ID: 35100813 [Abstract] [Full Text] [Related]
7. Disruption of renal tubular mitochondrial quality control by Myo-inositol oxygenase in diabetic kidney disease. Zhan M, Usman IM, Sun L, Kanwar YS. J Am Soc Nephrol; 2015 Jun 01; 26(6):1304-21. PubMed ID: 25270067 [Abstract] [Full Text] [Related]
8. Transcriptional and Translational Modulation of myo-Inositol Oxygenase (Miox) by Fatty Acids: IMPLICATIONS IN RENAL TUBULAR INJURY INDUCED IN OBESITY AND DIABETES. Tominaga T, Dutta RK, Joladarashi D, Doi T, Reddy JK, Kanwar YS. J Biol Chem; 2016 Jan 15; 291(3):1348-67. PubMed ID: 26578517 [Abstract] [Full Text] [Related]
9. Myo-inositol Oxygenase (MIOX) Overexpression Drives the Progression of Renal Tubulointerstitial Injury in Diabetes. Sharma I, Deng F, Liao Y, Kanwar YS. Diabetes; 2020 Jun 15; 69(6):1248-1263. PubMed ID: 32169892 [Abstract] [Full Text] [Related]
10. Contribution of myo-inositol oxygenase in AGE:RAGE-mediated renal tubulointerstitial injury in the context of diabetic nephropathy. Sharma I, Tupe RS, Wallner AK, Kanwar YS. Am J Physiol Renal Physiol; 2018 Jan 01; 314(1):F107-F121. PubMed ID: 28931523 [Abstract] [Full Text] [Related]
11. Development of an immunoassay for the kidney-specific protein myo-inositol oxygenase, a potential biomarker of acute kidney injury. Gaut JP, Crimmins DL, Ohlendorf MF, Lockwood CM, Griest TA, Brada NA, Hoshi M, Sato B, Hotchkiss RS, Jain S, Ladenson JH. Clin Chem; 2014 May 01; 60(5):747-57. PubMed ID: 24486646 [Abstract] [Full Text] [Related]
12. Pathobiology of renal-specific oxidoreductase/myo-inositol oxygenase in diabetic nephropathy: its implications in tubulointerstitial fibrosis. Xie P, Sun L, Oates PJ, Srivastava SK, Kanwar YS. Am J Physiol Renal Physiol; 2010 Jun 01; 298(6):F1393-404. PubMed ID: 20335317 [Abstract] [Full Text] [Related]
13. Up-regulation of human myo-inositol oxygenase by hyperosmotic stress in renal proximal tubular epithelial cells. Prabhu KS, Arner RJ, Vunta H, Reddy CC. J Biol Chem; 2005 May 20; 280(20):19895-901. PubMed ID: 15778219 [Abstract] [Full Text] [Related]
14. Transcriptional and post-translational modulation of myo-inositol oxygenase by high glucose and related pathobiological stresses. Nayak B, Kondeti VK, Xie P, Lin S, Viswakarma N, Raparia K, Kanwar YS. J Biol Chem; 2011 Aug 05; 286(31):27594-611. PubMed ID: 21652700 [Abstract] [Full Text] [Related]
15. Increased expression of myo-inositol oxygenase is involved in the tubulointerstitial injury of diabetic nephropathy. Lu Y, Liu C, Miao X, Xu K, Wu X, Liu C. Exp Clin Endocrinol Diabetes; 2009 Jun 05; 117(6):257-65. PubMed ID: 19053028 [Abstract] [Full Text] [Related]
16. Modulation of Renal Injury by Variable Expression of Myo-Inositol Oxygenase (MIOX) via Perturbation in Metabolic Sensors. Sharma I, Deng F, Kanwar YS. Biomedicines; 2020 Jul 16; 8(7):. PubMed ID: 32708636 [Abstract] [Full Text] [Related]
17. High Glucose-Induced Hypomethylation Promotes Binding of Sp-1 to Myo-Inositol Oxygenase: Implication in the Pathobiology of Diabetic Tubulopathy. Sharma I, Dutta RK, Singh NK, Kanwar YS. Am J Pathol; 2017 Apr 16; 187(4):724-739. PubMed ID: 28208054 [Abstract] [Full Text] [Related]
18. Role of myo-inositol in acute kidney injury induced by cisplatin. Xie YH, Wang L, Li ML, Gong ZC, Du J. Toxicology; 2023 Nov 16; 499():153653. PubMed ID: 37863467 [Abstract] [Full Text] [Related]
19. The Kidney Specific Protein myo-Inositol Oxygenase, a Potential Biomarker for Diabetic Nephropathy. Gao P, Xu B, Song P, Zhu X, Yuan S, Kanwar YS, Sun L. Kidney Blood Press Res; 2018 Nov 16; 43(6):1772-1785. PubMed ID: 30504713 [Abstract] [Full Text] [Related]
20. NADPH oxidase 4 promotes cisplatin-induced acute kidney injury via ROS-mediated programmed cell death and inflammation. Meng XM, Ren GL, Gao L, Yang Q, Li HD, Wu WF, Huang C, Zhang L, Lv XW, Li J. Lab Invest; 2018 Jan 16; 98(1):63-78. PubMed ID: 29106395 [Abstract] [Full Text] [Related] Page: [Next] [New Search]